|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 90 of 459 found articles
| Title: |
150MO Safety results from the phase IIIb SIERRA study of durvalumab (D) and tremelimumab (T) as first-line (1L) treatment (tx) for hepatocellular carcinoma (HCC) participants (pts) with a poor prognosis |
| Author: |
Chan, S.L. Kudo, M. Sangro, B. Kelley, R.K. Kim, J.H. Van Binh, P. Hong, J.Y. Waldschmidt, D.T. Marino, D. Gerolami, R. Li, Q. Nakamura, H. Sun, P. Baur, B. Rimassa, L. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 36 () nr. S1 pages S63-S64 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 90 of 459 found articles
| << previous | next >> |